Md Abu Bakar BAKAR Siddiq

Dr. Md Abu Bakar BAKAR Siddiq


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2020 in Turkish Journal of Physical Medicine and Rehabilitation
Verified
Journal Article
Open access
MSMd Abu Bakar BAKAR Siddiq
Md Abu Bakar BAKAR Siddiq
FRFarooq Azam Rathore
Farooq Azam Rathore
DCDanny Clegg
Danny Clegg
JRJohannes J Rasker
Johannes J Rasker
The novel coronavirus-2019 (COVID-19) pandemic primarily affects the respiratory system. Elderly individuals with comorbidity are severely affected. Survivors weaned from mechanical ventilation are at a higher risk of developing post-intensive care syndrome (PICS). This scoping review, based on 40 recent publications, highlights pulmonary rehabilitation (PR) in COVID-19. There is a paucity of high-quality research on this topic. However, rehabilitation societies including the Turkish Society of Physical Medicine and Rehabilitation have issued PR recommendations in COVID-19 pneumonia with productive cough can benefit from diaphragmatic breathing, pursed-lip breathing, and resistance-breathing training. Besides, those in mechanical ventilation and post-PICS COVID-19 cases, oxygen therapy, early mobilization, airway clearance, aerobic exercise, gradual-graded limb muscle resistance exercise, nutritional and psychological interventions should be consideration. During PR, careful evaluation of vital signs and exercise-induced symptoms is also required. When in-person PR is not possible, telerehabilitation should be explored. However, the long-term effects of PR in COVID-19 need further evaluation.

27 April 2024 in Joint Bone Spine
Verified
Journal Article
Open access
MSMd Abu Bakar BAKAR Siddiq
Md Abu Bakar BAKAR Siddiq
WOWin Min Oo
Win Min Oo
DHDavid J. Hunter
David J. Hunter
Osteoarthritis (OA) is the most prevalent arthritis-type and is a major contributor to chronic joint pain, impaired physical function, and limited mobility. By the end of 2020, a total of 595 million, equal to 7·6% of the global population, had OA; this figure is expected to rise exponentially by 2050. Even while the disorder's intricate pathophysiology is starting to appear intelligible, we are yet to have a cure for the disorder. OA is typically managed with traditional palliative measures, such as topical and systemic analgesics, including non-steroidal anti-inflammatory drugs, therapeutic exercise, and braces. Sometimes, intra-articular glucocorticoids, viscosupplementation, or regenerative interventions provide short-term pain relief and functional improvement; some may require arthroplasty. Researchers continue their efforts to unveil a new therapeutic target to be effective in OA that modifies symptoms and arrests disease progression as well. In the present literature review, insights into new therapeutic strategies in OA, for example, liposome-based dexamethasone, microspore-based triamcinolone, nerve growth factor antagonist, anti-ADAMTS-5 (A Disintegrin And Metalloproteinase Thrombospoidin Motifs - 5), pentosan polysulfate sodium, allogeneic stem cells, C-C chemokine receptor type-4 (CCR4) ligand 17 inhibitor, Wnt-signaling inhibitor, and anti-obesity medications are provided.

19 September 2016 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
MSMd Abu Bakar BAKAR Siddiq
Md Abu Bakar BAKAR Siddiq
SHShawkat Hossain
Shawkat Hossain
MUMohammad Moin Uddin
Mohammad Moin Uddin
IJIsrat Jahan
Israt Jahan
MKMoshiur Rahman Khasru
Moshiur Rahman Khasru
JRJohannes J. Rasker
Johannes J. Rasker

2 May 2019 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
MSMd Abu Bakar BAKAR Siddiq
Md Abu Bakar BAKAR Siddiq
JRJohannes Jacobus Rasker
Johannes Jacobus Rasker

1 October 2020 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
MSMd Abu Bakar BAKAR Siddiq
Md Abu Bakar BAKAR Siddiq
DCDanny Clegg
Danny Clegg
SHSuzon Al Hasan
Suzon Al Hasan
Johannes J RaskerJohannes J Rasker
Johannes J Rasker
Md Abu Bakar Siddiq, Danny Clegg, Suzon Al Hasan, and Johannes J Rasker. Korean J Pain 2020;33:305-17. https://doi.org/10.3344/kjp.2020.33.4.305

10 May 2018 in Cureus
Verified
Journal Article
Open access
PDF file
MSMd Abu Bakar BAKAR Siddiq
Md Abu Bakar BAKAR Siddiq
Piriformis syndrome (PS) involves the piriformis muscle and adjacent sciatic nerve, producing features similar to true sciatica of lumbar spine origin, for example, lumbar disc prolapse, thereby confusing pain physicians about the diagnosis. Synonyms that are used frequently for PS are deep gluteal syndrome, extra-spinal sciatica, wallet neuritis, etc. Commonly presenting symptoms of PS include gluteal pain which increases with affected side sitting/per-rectal manoeuvre, and improves with ambulation/intra-lesional steroid, etc. Among various PS associations, wallet neuritis is one of them. However, the latter condition can present with even without the typical features for PS, such as positive flexion adduction internal rotation (FAIR) test, pace sign, etc. In a situation like this, mere discontinuation with fatty buttock wallet is often sufficient for relieving patients’ discomfort, making other approaches unnecessary for the patient (though these approaches are warranted for many PS manifestations). Thus, it would not be wise to use piriformis syndrome and wallet neuritis terminology interchangeably as depicted in many published papers.